{"title":"艾滋病政策和药品专利:巴西保障公众健康的战略","authors":"J. C. Cohen, Kristina M.L. Acri née Lybecker","doi":"10.1111/J.1467-9701.2005.00668.X","DOIUrl":null,"url":null,"abstract":"Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the Brazilian pharmaceutical sector, their public health system and the Brazilian AIDS policy, this paper examines the Brazilian strategy vis-a-vis the international pharmaceutical manufacturers to explore why their tactics were successful and the potential for wider application by other developing countries.","PeriodicalId":73765,"journal":{"name":"Journal of health care law & policy","volume":"46 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2005-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"17","resultStr":"{\"title\":\"Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health\",\"authors\":\"J. C. Cohen, Kristina M.L. Acri née Lybecker\",\"doi\":\"10.1111/J.1467-9701.2005.00668.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the Brazilian pharmaceutical sector, their public health system and the Brazilian AIDS policy, this paper examines the Brazilian strategy vis-a-vis the international pharmaceutical manufacturers to explore why their tactics were successful and the potential for wider application by other developing countries.\",\"PeriodicalId\":73765,\"journal\":{\"name\":\"Journal of health care law & policy\",\"volume\":\"46 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"17\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of health care law & policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1467-9701.2005.00668.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of health care law & policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1467-9701.2005.00668.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Aids Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health
Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the Brazilian pharmaceutical sector, their public health system and the Brazilian AIDS policy, this paper examines the Brazilian strategy vis-a-vis the international pharmaceutical manufacturers to explore why their tactics were successful and the potential for wider application by other developing countries.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
